$28.90 $1.92 per serving
Product analysis
3-in-1 Joint Formula may offer modest support for joint comfort, though the evidence depends on particular ingredient preparations. Unclear preparation details make the likely benefit of this combination harder to judge.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
Most ingredient preparations are unspecified, limiting a clear comparison of quality. Part of the ingredient identity is also unclear, so the full combination cannot be judged confidently.
Ingredient Transparency67
Most amounts are stated, but preparation forms are largely unspecified. Most applicable composition details are available, with one part still unresolved.
Value For Money40
Potassium offers favourable value at the full serving cost, while folate is costly relative to its contribution. Value remains uncertain for most other ingredients, including omega-3.
Customer Satisfaction75
Customer feedback is positive. More than a thousand ratings provide a substantial base for judging satisfaction.
Product Focus45
Some joint ingredients have modest comfort findings, but those findings depend on particular preparations. The broad mixture and unclear individual preparations limit how confidently they apply to this formula.
- Format
Softgel - Container
- 90 Softgel(s)
- Per serving
- $1.92
- Customer rating
- 4.4 · 1,208 ratings
Goals
Impact
Situational effect
Fish Oil · 3180 mgVitamin E · 10 mgBoswellia · 115 mg
Impact
High effect
Potassium · 250 mgFish Oil · 3180 mgVitamin B12 · 120 mcgVitamin E · 10 mgFolate · 225 mcgNiacin · 23 mg
Impact
High effect
Vitamin E · 10 mgOmega-3 · 1035 mg
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 60 Calorie(s) | |
Total Fat | 3.5 Gram(s) | |
Saturated Fat | 1 Gram(s) | |
Cholesterol | 15 mg | |
Total Carbohydrates | 3 Gram(s) | |
Dietary Fiber | 1 Gram(s) | |
Protein | 3 Gram(s) | |
Vitamin E (D-Alpha-Tocopherol) | 10 mg | |
Niacin (Niacinamide) | 23 mg | |
Folate | 382 mcg DFE | |
Folic Acid | 225 mcg | |
Vitamin B12 (Cyanocobalamin) | 120 mcg | |
Manganese (Manganese Gluconate) | 7 mg | |
Sodium | 95 mg | |
Potassium | 250 mg | |
Fish Oils | 3180 mg | |
Omega-3 Fatty Acids | 1035 mg | |
Glucosamine Sulfate (Glucosamine Sulfate 2KCl) | 1500 mg | |
Chondroitin Sulfate | 1200 mg | |
Flaxseed Oil | 150 mg | |
Methylsulfonylmethane | 150 mg | |
Indian Frankincense gum resin extract | 115 mg | |
Boswellic Acids | 74.75 mg | |
Stinging Nettle leaf extract | 70 mg | |
Phytosterols | 0.56 mg | |
Turmeric root extract | 40 mg | |
Curcuminoids | 38 mg | |
Alpha-Lipoic Acid | 5 mg | |
BioPerine Complex | 6 mg | |
Bioperine (Black Pepper Fruit Extract) | 0 NP | |
Ginger Rhizome Extract (Gingerols) | 0 NP |
Manganese (Manganese Gluconate) · 7 mg OverallScore85
Niacin (Niacinamide) · 23 mg OverallScore64
Boswellia · 115 mg OverallScore80
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
- Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
- A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
- Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
- Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
- Effect of flaxseed supplementation on blood pressure: a systematic review, and dose-response meta-analysis of randomized clinical trials.
- Dietary supplementation with flaxseed oil lowers blood pressure in dyslipidaemic patients.
- Flaxseed reduces total and LDL cholesterol concentrations in Native American postmenopausal women.
- Effect of flaxseed on blood lipid level in hyperlipidemic patients.
- Effects of flaxseed on blood pressure, body mass index, and total cholesterol in hypertensive patients: A randomized clinical trial.
- Associations of dietary folate, vitamin B6 and B12 intake with cardiovascular outcomes in 115664 participants: a large UK population-based cohort.
- Folate, Homocysteine, and Adverse Outcomes After Ischemic Stroke.
- Effect of folic acid on endothelial function following acute myocardial infarction.
- Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial.
- 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia.
- The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression.
- Effects of niacin on apo A1 and B levels: a systematic review and meta-analysis of randomised controlled trials.
- Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis of randomized controlled trials.
- Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.
- Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia.